A reduced number of calcium-sensing receptors and vitamin D receptors in areas of nodular transformation may contribute both to the progression of SHPT and to the abnormal proliferation of parathyroid cells, leading to the formation of a hyperfunctioning parathyroid nodule or adenoma in patients with ESRD [49]. This evidence concerns the gene CASR and adenoma.